✦ LIBER ✦

Safety trial using the Leishmune® vaccine against canine visceral leishmaniasis in Brazil

✍ Scribed by L.E. Parra; G.P. Borja-Cabrera; F.N. Santos; L.O.P. Souza; C.B. Palatnik-de-Sousa; I. Menz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity assay of the Leishmune® v

✍ G.P. Borja-Cabrera; F.N. Santos; F.S. Bauer; L.E. Parra; I. Menz; A.A. Morgado; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 170 KB

The FML-vaccine (Leishmune®) against can

✍ Elvira M. Saraiva; André de Figueiredo Barbosa; Fernanda Nunes Santos; Gulnara P 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Immunotherapy against experimental canin

✍ F.N. Santos; G.P. Borja-Cabrera; L.M. Miyashiro; J. Grechi; A.B. Reis; M.A.B. Mo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 359 KB

Immunotherapy with the saponin enriched-

✍ G.P. Borja-Cabrera; F.N. Santos; F.B. Santos; Fernando Antonio de A. Trivellato; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 357 KB

The Leishmune®́s Nucleoside hydrolase DN

✍ Borja-Cabrera, Gulnara P.; Santos, Flavia B.; Nico, Dirlei; Gravino, A.E.; Manna 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 556 KB

Decrease of the incidence of human and c

✍ Clarisa B. Palatnik-de-Sousa; Ilce Silva-Antunes; Adilson de Aguiar Morgado; Ing 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 416 KB